Cargando…

Treatments for chronic psychosis

Psychosis is a mental condition characterized by hallucinations, delusions, and thought disorder; it spans diagnostic entities that respond to similar therapeutic approaches. Psychosis has no fully described tissue pathology, as vet, but is still identified and assessed symptomatically. The first ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamminga, Carol A., Lahti, Adrienne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181661/
https://www.ncbi.nlm.nih.gov/pubmed/22033485
_version_ 1782212783898624000
author Tamminga, Carol A.
Lahti, Adrienne C.
author_facet Tamminga, Carol A.
Lahti, Adrienne C.
author_sort Tamminga, Carol A.
collection PubMed
description Psychosis is a mental condition characterized by hallucinations, delusions, and thought disorder; it spans diagnostic entities that respond to similar therapeutic approaches. Psychosis has no fully described tissue pathology, as vet, but is still identified and assessed symptomatically. The first generation of antipsychotic drugs was developed in the middle of the 20th century. The second generation of drugs arrived in the 1990s. This new group of antipsychotic drugs has potent therapeutic actions on the positive symptoms of psychosis with far fewer side effects, especially motor effects. However, each of the new drugs has its own characteristic clinical and pharmacological features that affect individual patient response. Understanding these individual drug characteristics can promote optimal drug choice and use in conditions of chronic psychosis.
format Online
Article
Text
id pubmed-3181661
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31816612011-10-27 Treatments for chronic psychosis Tamminga, Carol A. Lahti, Adrienne C. Dialogues Clin Neurosci Clinical Research Psychosis is a mental condition characterized by hallucinations, delusions, and thought disorder; it spans diagnostic entities that respond to similar therapeutic approaches. Psychosis has no fully described tissue pathology, as vet, but is still identified and assessed symptomatically. The first generation of antipsychotic drugs was developed in the middle of the 20th century. The second generation of drugs arrived in the 1990s. This new group of antipsychotic drugs has potent therapeutic actions on the positive symptoms of psychosis with far fewer side effects, especially motor effects. However, each of the new drugs has its own characteristic clinical and pharmacological features that affect individual patient response. Understanding these individual drug characteristics can promote optimal drug choice and use in conditions of chronic psychosis. Les Laboratoires Servier 2001-12 /pmc/articles/PMC3181661/ /pubmed/22033485 Text en Copyright: © 2001 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Tamminga, Carol A.
Lahti, Adrienne C.
Treatments for chronic psychosis
title Treatments for chronic psychosis
title_full Treatments for chronic psychosis
title_fullStr Treatments for chronic psychosis
title_full_unstemmed Treatments for chronic psychosis
title_short Treatments for chronic psychosis
title_sort treatments for chronic psychosis
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181661/
https://www.ncbi.nlm.nih.gov/pubmed/22033485
work_keys_str_mv AT tammingacarola treatmentsforchronicpsychosis
AT lahtiadriennec treatmentsforchronicpsychosis